Highlight
- Postoperative recurrence of Crohn’s disease involves distinct shifts in the mucosa-associated microbiota, notably decreases in Faecalibacterium prausnitzii and increases in Akkermansia muciniphila.
- The Rutgeerts score, measuring endoscopic recurrence severity, relates to specific microbial signatures, emphasizing the value of multilevel microbiota analysis rather than binary classification.
- Network analysis reveals a denser microbial community after surgery in patients without recurrence, indicating dynamic ecosystem reorganization related to disease status.
- The study integrates microbial compositional changes with clinical outcomes, advancing our understanding of post-ileal resection Crohn’s disease pathophysiology.
Study Background
Crohn’s disease (CD) is a chronic, relapsing inflammatory bowel disease affecting the gastrointestinal tract, frequently requiring surgical intervention. Approximately 50% to 75% of patients with CD undergo bowel resection during their disease course to manage complications or refractory inflammation. However, postoperative recurrence is a well-recognized challenge, typically assessed endoscopically using the Rutgeerts score, which grades inflammation severity at the neo-terminal ileum and anastomosis. Despite its clinical importance, the pathophysiological processes underpinning microbiota changes in the postoperative mucosa and their relationship to recurrence remain inadequately understood. Unraveling these microbial dynamics could inform prophylactic and therapeutic strategies to prevent recurrence.
Study Design
This multicenter study by Dubois et al. profiled mucosa-associated microbiota in CD patients undergoing ileal resection. Biopsies from 139 subjects were sampled at the time of surgery (M0) and from 125 subjects during follow-up endoscopic surveillance 6 months postoperatively (M6). The Rutgeerts score was employed to stratify recurrence severity, capturing a gradient of mucosal inflammation. Microbial profiling utilized 16S ribosomal RNA gene sequencing for bacteria and ITS2 sequencing for fungal communities. Analytical approaches included relative abundance comparisons adjusted for clinical covariates, machine learning for predictive modeling, and community ecology network analyses to explore microbial interactions and keystone species dynamics.
Key Findings
The study revealed that while surgery and recurrence exerted moderate overall effects on microbial community composition, specific taxa exhibited significant differential abundance linked to recurrence grades.
Notably, the anti-inflammatory commensal Faecalibacterium prausnitzii showed diminished abundance correlating with higher Rutgeerts scores and increased mucosal inflammation. Conversely, Akkermansia muciniphila – a mucin-degrading bacterium sometimes implicated in mucosal health and disease – increased as recurrence severity escalated. These taxa changes were compartmentalized, differing between inflammatory involvement at the anastomosis versus the ileum itself.
Importantly, machine learning models demonstrated enhanced predictive performance when the full spectrum of the Rutgeerts score was incorporated, underscoring the value of multilevel phenotyping beyond simple binary classifications (recurrence vs no recurrence).
Community network analysis uncovered a more tightly organized microbiota network post-surgery in patients without recurrence, indicating resilience and stability in microbial interactions. Keystone species within these networks altered dynamically in relation to recurrence status, revealing complex ecosystem remodeling during disease progression.
Expert Commentary
These findings align with growing evidence that mucosal microbial communities are intimately involved in CD pathology and postoperative disease behavior. Faecalibacterium prausnitzii has been consistently associated with anti-inflammatory effects through butyrate production; its depletion postoperatively likely contributes to mucosal vulnerability and recurrence. Meanwhile, the role of Akkermansia muciniphila is nuanced and may reflect attempts at mucosal healing or dysregulated mucin degradation.
The study’s comprehensive approach, integrating microbial profiling with clinical parameters and advanced analytical modeling, represents a methodological strength, yet limitations exist. These include the cross-sectional design at M6 limiting causal inference and potential confounders like antibiotic use or immunosuppressive therapy influencing microbiota.
Future longitudinal studies incorporating functional metagenomics and host immune profiling may further elucidate mechanistic pathways. These insights could pave the way for microbiota-targeted interventions, such as probiotics or fecal microbiota transplantation, tailored to modulate key microbial players and prevent recurrence.
Conclusion
This study advances our understanding of the dynamic mucosal microbiota landscape after ileal resection in Crohn’s disease and its association with postoperative recurrence. The data support a view of recurrence as a complex, multi-phasic process involving shifts in key microbial taxa and network structures. Importantly, leveraging the full range of endoscopic disease severity enhances microbiota-based predictive modeling.
Clinically, these insights highlight potential microbial biomarkers for early detection of recurrence risk and therapeutic targets to restore a protective microbiota ecosystem, ultimately aiming to improve postoperative outcomes in Crohn’s disease management.
Funding and ClinicalTrials.gov
The original study was conducted by a large collaborative group (REMIND Group) and published in Gastroenterology. Specific funding details are reported in the primary publication. No clinical trial registration was indicated for this observational microbiota profiling study.
References
Dubois L, Chaussard A, Seksik P, et al. Uncovering the Dynamics of Mucosa-Associated Microbiota in Postoperative Recurrence of Crohn’s Disease. Gastroenterology. 2026 Feb 24;171(1):84-98. PMID: 41747778.
Sokol H, Seksik P, Furet J-P, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009 Aug;15(8):1183-9.
Miquel S, Martín R, Rossi O, et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013 Jun;16(3):255-61.
Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008 May 29;453(7195):620-5.
Borren NZ, van Nood E, Nieuwdorp M, et al. Fecal microbiota transplantation impacts on restoration of mucosal barrier function in inflammatory bowel disease. Therap Adv Gastroenterol. 2020;13:1756284820926334.
Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014 Aug;63(8):1275-83.
Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016 Jul 7;535(7610):75-84.
